Understand the language of medical and pharmaceutical communications.
Simple explanations of the terms, abbreviations and concepts you'll encounter throughout SciNarris.
Start with the basics or browse by topic.
"A person involved in providing healthcare, such as a physician, pharmacist or other qualified healthcare professional."
"An institution or entity providing healthcare services or clinical research."
"Communications or educational materials directed directly at patients or the general public."
"A planned scientific study involving human participants designed to evaluate a medical intervention."
"Scientific data and findings generated through clinical research evaluating a medicine."
"Peer-reviewed journal articles reporting original research data directly from clinical studies."
"Publications that synthesize, review, or summarize original findings reported elsewhere."
"The control treatment (placebo or active standard-of-care drug) against which a study drug is evaluated."
"A predefined quantitative outcome measured in a clinical study to assess treatment effects."
"The main target outcome a clinical trial was specifically designed and statistically powered to evaluate."
"Additional clinical outcomes evaluated to provide supplementary insight into treatment effects."
"The field dedicated to developing accurate, educational, and promotional scientific materials for healthcare audiences."
"Healthcare communications designed to foster awareness, brand appreciation, or prescribing consideration for an approved product."
"Unbranded educational materials or pure scientific exchange conducted without commercial intent."
"The specialized discipline of writing clear, engaging, and compliant copy for pharmaceutical promotional materials."
"A structured visual booklet or folder used by sales representatives to present product data to healthcare professionals."
"An interactive tablet app or digital presentation used to present interactive clinical data to prescribers."
"A concise printed summary card or brochure left with a healthcare professional following a detail presentation."
"Any visual or printed presentation tool utilized during pharmaceutical representative meetings."
"A statement communicating a benefit, attribute, efficacy result, safety profile, or characteristic of a medicine."
"A claim presented within commercial materials designed to highlight product advantages to prescribers."
"The process of providing verified scientific evidence to back up every assertion made in a promotional piece."
"The specific scientific publication or monograph source cited to support a statement or claim."
"The superscript or numerical tag in text linking a claim directly to its reference entry."
"The mandatory standard requiring promotional materials to present safety and risk information alongside benefit claims."
"A review process in which medical communications are assessed from medical, legal and regulatory perspectives."
"The evaluation conducted by medical directors to verify scientific accuracy and data interpretation."
"Review by legal counsel evaluating trademark usage, copyright compliance, and corporate risk."
"Evaluation by regulatory affairs specialists ensuring alignment with advertising codes and monograph limits."
"Canada's independent national health product advertising pre-clearance organization."
"The formal file containing layout drafts, annotated copy, references, and monograph submitted to PAAB for review."
"The practice of writing promotional text specifically formatted to meet PAAB Code standards."
"The official clinical summary document approved by regulatory authorities detailing drug indications, dosing, and safety."
"Comprehensive prescribing details including indications, dosage, contraindications, and warnings."
"The specific disease or clinical condition for which a medicine has received official regulatory marketing authorization."
"The capacity of a medicine to produce a desired therapeutic effect under ideal controlled trial conditions."
"How well a medicine works when used in routine real-world clinical practice across diverse patient populations."
"The evaluation of risks, adverse reactions, and tolerability observed during drug exposure."
"Any untoward or unintended medical occurrence experienced by a patient during drug treatment."